SCHEMBL23749288

SCHEMBL23749288

CCOc1ccn(Cc2ccc(F)cc2)c(=O)c1C(=O)Cl

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.48
GAA P10253 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ALDH1A1 P00352 3/20 0.46
CNR2 P34972 2/20 0.46
FAAH O00519 1/20 0.46
CNR1 P21554 1/20 0.46
MAPT P10636 4/20 0.46
THRB P10828 2/20 0.46
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TP53 P04637 1/20 0.41
HCRTR2 O43614 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
PTGER3 P43115 1/20 0.40
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15506048 0.90 MAPK14 (0.48) MAPK14GAAL3MBTL1ALDH1A1CNR2
SCHEMBL23749552 0.87 MAPK14 (0.54) MAPK14ALDH1A1MAPTTHRBKDM4E
SCHEMBL2592272 0.81 MET (0.51) ALDH1A1MAPTKDM4ESMN1; SMN2TSHR
SCHEMBL30030303 0.76 MAPK14 (0.53) MAPK14ALDH1A1MAPTTHRBKDM4E
SCHEMBL23749279 0.75 MET (0.42) L3MBTL1CNR2CNR1MAPT
SCHEMBL2592829 0.74 CYP1A2 (0.39) L3MBTL1ALDH1A1FAAHMAPTTHRB
SCHEMBL23749466 0.72 AXL (0.43) L3MBTL1ALDH1A1THRBMEN1KMT2A
SCHEMBL30031376 0.72 AXL (0.43) L3MBTL1ALDH1A1THRBMEN1KMT2A
SCHEMBL25612867 0.72 CNR2 (0.62) GAAL3MBTL1ALDH1A1CNR2FAAH
SCHEMBL23749427 0.72 PTGS1 (0.39) GAAL3MBTL1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220002308-A1 AROMATIC RING-LINKED DIOXINO-QUINAZOLINE OR DIOXINO-QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2022-01-06 US disclosed
EP-3865487-A1 AROMATIC RING-LINKED DIOXANE-QUINAZOLINE OR -QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF Beijing Scitech-MQ Pharmaceuticals Limited (CN) 2021-08-18 EP disclosed
EP-3865487-A1 AROMATIC RING-LINKED DIOXANE-QUINAZOLINE OR -QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF Beijing Scitech-MQ Pharmaceuticals Limited (CN) 2021-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220002308-A1 AROMATIC RING-LINKED DIOXINO-QUINAZOLINE OR DIOXINO-QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF MERTK, AXL, TYRO3 MAPK14 485/4885GAA 2781/4885L3MBTL1 3388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.